Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$807M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$497M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$390M |
| 4 |
Kenvue
KVUE
|
+$379M |
| 5 |
Broadcom
AVGO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$409M |
| 2 |
Visa
V
|
+$354M |
| 3 |
Advanced Micro Devices
AMD
|
+$328M |
| 4 |
Meta Platforms (Facebook)
META
|
+$317M |
| 5 |
Lockheed Martin
LMT
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.61% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 8.17% |
| 4 | Industrials | 8.1% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
W.W. Grainger
GWW
$61.8B
| $49.2M | 0.06% |
48,735
-12,175
| -20% | -$11.8M |
|
352
Netflix
NFLX
$331B
| $49M | 0.06% |
522,852
+488,212
| +1,409% | +$52.6M |
|
353
American Tower
AMT
$81.9B
| $48.9M | 0.06% |
+278,398
| New | +$50.7M |
|
354
Meritage Homes
MTH
$4.67B
| $48.8M | 0.06% |
741,277
-385,283
| -34% | -$26.7M |
|
355
UMB Financial
UMBF
$11B
| $48.6M | 0.06% |
422,065
+388,253
| +1,148% | +$44M |
|
|
ABVX
356
Abivax
ABVX
$10B
| $48.3M | 0.06% |
358,322
+198,102
| +124% | +$21.6M |
|
357
GFL Environmental
GFL
$14.8B
| $48.3M | 0.06% |
1,124,140
+834,470
| +288% | +$37.3M |
|
358
PUT
Zoom
ZM
$31.5B
| $47.8M | 0.06% |
553,800
+95,100
| +21% | +$8M |
|
359
Chipotle Mexican Grill
CMG
$46.7B
| $47.6M | 0.06% |
1,285,843
+1,027,061
| +397% | +$37.2M |
|
360
Bank of Hawaii
BOH
$3.06B
| $47.5M | 0.06% |
694,103
-318,457
| -31% | -$21M |
|
361
Bunge Global
BG
$21.7B
| $47.3M | 0.06% |
530,964
+508,653
| +2,280% | +$46.9M |
|
362
Sprouts Farmers Market
SFM
$7.56B
| $47.1M | 0.06% |
590,664
+418,145
| +242% | +$37.5M |
|
363
Tango Therapeutics
TNGX
$4.03B
| $46.8M | 0.06% |
5,278,580
+1,806,373
| +52% | +$15.6M |
|
364
e.l.f. Beauty
ELF
$6.02B
| $46.4M | 0.06% |
609,917
+286,170
| +88% | +$28.2M |
|
365
Chewy
CHWY
$9.83B
| $46M | 0.06% |
1,392,277
-99,090
| -7% | -$3.44M |
|
|
RAL
366
Ralliant Corp
RAL
$7.04B
| $45.7M | 0.06% |
898,360
+113,646
| +14% | +$5.33M |
|
|
LBRDK
367
DELISTED
Liberty Broadband Class C
LBRDK
| $45.7M | 0.06% |
939,599
+120,721
| +15% | +$6.28M |
|
368
Abercrombie & Fitch
ANF
$4.84B
| $45.7M | 0.06% |
362,779
-119,882
| -25% | -$10.5M |
|
369
Agree Realty
ADC
$9.19B
| $45.6M | 0.06% |
633,227
-994,656
| -61% | -$72.7M |
|
370
Toyota
TM
$234B
| $45.4M | 0.06% |
211,904
-14,920
| -7% | -$3.03M |
|
371
PUT
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
| $45.3M | 0.06% |
583,500
-681,500
| -54% | -$53.2M |
|
|
THS
372
DELISTED
Treehouse Foods
THS
| $45M | 0.06% |
+1,907,053
| New | +$41.6M |
|
|
CAI
373
Caris Life Sciences
CAI
$7.42B
| $44.8M | 0.06% |
1,660,280
+1,653,363
| +23,903% | +$46.6M |
|
374
ATI
ATI
$28.2B
| $44.8M | 0.06% |
+389,986
| New | +$38M |
|
|
ARX
375
Accelerant Holdings
ARX
$4.25B
| $44.7M | 0.06% |
2,733,595
+714,811
| +35% | +$10.1M |
|
Similar funds
Dmitry Balyasny's Q4 2025 Portfolio in Review
As of Q4 2025, Dmitry Balyasny held 3,669 positions worth $78.8B, down 0.17% from $78.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Dmitry Balyasny withdrew a net $4.13B in Q4 2025, closing 643 positions and reducing 1,102 holdings. Its most notable exit was Mr. Cooper, an estimated $277M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Dmitry Balyasny opened a new position in Avidity Biosciences worth $436M.
- Dmitry Balyasny's largest Q4 2025 buy was Avidity Biosciences: 6,040,590 shares worth $436M.
- Dmitry Balyasny added most to Amazon in Q4 2025, an estimated $807M increase.
- Dmitry Balyasny's biggest Q4 2025 reduction was Apple, cutting an estimated $409M.
- Dmitry Balyasny fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Dmitry Balyasny's ten largest holdings make up 15% of its $78.8B portfolio in Q4 2025.
- Dmitry Balyasny opened 809 new positions and closed 643 in Q4 2025.
- Dmitry Balyasny's portfolio value fell 0.17% quarter-over-quarter to $78.8B.
Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.